Delivery Order SPE2DB22D2007-SPE2DB25FJ5DT
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 12.5 mg hydrochlorothiazide tablets. The $3,426.72 delivery order has a completion date of February 21, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this order, which is placed under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,437.51 firm fixed-price delivery order is for the supply of 4,564,864,496 units of Hydrochlorothiazide 12.5 mg tablets in 1000-count bottles. The award has a completion date of June 11, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of hydrochlorothiazide 12.5 mg tablets in 1,000 count units. The $1,607.24 Firm Fixed Price contract was awarded by the Defense Logistics Agency (DLA), a Defense agency, on June 13, 2024 with a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award is for the delivery of hydrochlorothiazide 25 mg tablets in quantities of 500 per order. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- The Defense Logistics Agency awarded a $22,920 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 12.5 mg hydrochlorothiazide tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support DLA's medical supply needs. The firm fixed price contract runs from July 5-6, 2023. No set aside designation or subcontractors were identified. DLA manages the global supply chain for the...
- The Defense Logistics Agency awarded a $9,360 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 bottles of 50mg hydrochlorothiazide tablets. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle. As a...
- The Defense Logistics Agency awarded a $91,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of 12.5 mg hydrochlorothiazide tablets. As a major supplier of pharmaceuticals to the Department of Defense through indefinite-delivery contracts, Amerisourcebergen will deliver the ordered products to a location in Conshohocken, Pennsylvania within the one-day period of performance specified between June 27-28, 2023. No subcontractors or set-aside...
- The Defense Logistics Agency Troop Support awarded a firm fixed price delivery order valued at approximately $28,000 to Amerisourcebergen Drug Corporation. The order is for 100 tablets of the generic drug hydrochlorothiazide 12.5 mg to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown location by August 23, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common diuretic medication supports...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ninety-one thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of one hundred tablets of twelve and a half milligram hydrochlorothiazide. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 31, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...
- This federal contract award is to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc., for the delivery of hydrochlorothiazide 12.5 mg tablets in 1,000-count bottles. The $2,483.77 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on January 3, 2023, with a completion date of January 4, 2023. This contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5DTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,884.66 to AmerisourceBergen Drug Corp for the supply of Hydrochlorothiazide 12.5 mg tablets in a quantity of 1,000 units. The contract employs firm fixed pricing and is classified as a non-competitive, non-set-aside award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 22, 2025. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen leverages this contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with essential medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/19/25 |